Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.48 |
| ▸ | CES1 | P23141 | 5/20 | 0.48 |
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | NAAA | Q02083 | 2/20 | 0.45 |
| ▸ | PAM | P19021 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8101007 | 1.00 | FAAH (0.48) | FAAHCES1CES2DGKAMEN1 | |
| SCHEMBL28790924 | 0.90 | FAAH (0.43) | FAAHCES1CES2DGKAMEN1 | |
| SCHEMBL28023360 | 0.83 | PAM (0.46) | DGKAMEN1KMT2AHSD17B10LMNA | |
| SCHEMBL29012826 | 0.80 | DGKA (0.51) | FAAHDGKALMNANAAAPAM | |
| SCHEMBL298835 | 0.79 | DGKA (0.53) | CES1CES2DGKAMEN1KMT2A | |
| SCHEMBL297943 | 0.79 | DGKA (0.53) | CES1CES2DGKAMEN1KMT2A | |
| SCHEMBL297510 | 0.79 | DGKA (0.53) | CES1CES2DGKAMEN1KMT2A | |
| SCHEMBL20576505 | 0.79 | DGKA (0.53) | CES1CES2DGKAMEN1KMT2A | |
| SCHEMBL22711539 | 0.79 | DGKA (0.53) | CES1CES2DGKAMEN1KMT2A | |
| SCHEMBL5446582 | 0.79 | DGKA (0.53) | CES1CES2DGKAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6635262-B2 | Hair composition containing at least one of (i) anionic, amphoteric, and nonionic fixing polymers; (ii) beneficial agents; and (iii) hair dyes; capable of directly depositing on the hair said at least one component. | L'OREAL S.A. (FR) | 2003-10-21 | — | — | US | disclosed |
| US-20030012758-A1 | Roll-on applicator comprising a hair composition | L'OREAL S.A. (FR) | 2003-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030012758-A1 | Roll-on applicator comprising a hair composition | SUCLG1, CUTA, ACR | FAAH 169/4885CES1 3944/4885CES2 2336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.